Photo from ESTRO/X The latest results from the PACE-C trial presented at ESTRO24 ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: . “Check out the latest results from the PACE-C trial that were presented at ESTRO24, comparing SBRT and MHRT for high-risk prostate cancer with ADT.” Source: ESTRO/X Insight ADT cancer Cancer research ESTRO ESTRO24 MHRT OncoDaily Oncology PACE-C trial prostate cancer SBRT